Alveolar nitric oxide concentration reflects peripheral airway obstruction in stable asthma

Respirology

Volumn 18, Issue 3, 2013, Pages 522-527

  Fujisawa, Tomoyuki ^a   Yasui, Hideki ^a   Akamatsu, Taisuke ^a   Hashimoto, Dai ^a   Enomoto, Noriyuki ^a   Inui, Naoki ^a   Nakamura, Yutaro ^a   Maekawa, Masato ^a   Suda, Takafumi ^a   Chida, Kingo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

alveolar nitric oxide; asthma; nitric oxide; peripheral airway obstruction; pulmonary function test

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ALVEOLAR NITRIC OXIDE CONCENTRATION; ARTICLE; ASTHMA; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE MARKER; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FRACTION OF EXHALED NITRIC OXIDE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS;

AIRWAY OBSTRUCTION; ASTHMA; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; PULMONARY ALVEOLI; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 84875675354     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12031     Document Type: Article

References (33)

1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008; 31: 143-178.
2. Carroll N, Carello S, Cooke C, et al. Airway structure and inflammatory cells in fatal attacks of asthma. Eur. Respir. J. 1996; 9: 709-715.
3. Carroll N, Cooke C, James A,. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur. Respir. J. 1997; 10: 292-300.
4. Faul JL, Tormey VJ, Leonard C, et al. Lung immunopathology in cases of sudden asthma death. Eur. Respir. J. 1997; 10: 301-307.
5. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 1505-1510.
6. Kraft M, Martin RJ, Wilson S, et al. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am. J. Respir. Crit. Care Med. 1999; 159: 228-234.
7. in 't Veen JC, Beekman AJ, Bel EH, et al. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am. J. Respir. Crit. Care Med. 2000; 161: 1902-1906.
8. Mauad T, Silva LF, Santos MA, et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 2004; 170: 857-862.
9. ten Brinke A, Zwinderman AH, Sterk PJ, et al. 'Refractory' eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am. J. Respir. Crit. Care Med. 2004; 170: 601-605.
10. Ueda T, Niimi A, Matsumoto H, et al. Role of small airways in asthma: investigation using high-resolution computed tomography. J. Allergy Clin. Immunol. 2006; 118: 1019-1025.
11. Kharitonov SA, Yates DH, Barnes PJ,. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 1996; 153: 454-457.
12. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 2005; 352: 2163-2173.
13. Hasegawa H, Inui N, Fujisawa T, et al. Once-daily inhaled glucocorticosteroid administration in controlled asthma patients. Pulm. Pharmacol. Ther. 2008; 21: 663-667.
14. Barnes PJ, Dweik RA, Gelb AF, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010; 138: 682-692.
15. Tsoukias NM, George SC,. A two-compartment model of pulmonary nitric oxide exchange dynamics. J. Appl. Physiol. 1998; 85: 653-666.
16. Condorelli P, Shin HW, Aledia AS, et al. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J. Appl. Physiol. 2007; 102: 417-425.
17. Lehtimaki L, Kankaanranta H, Saarelainen S, et al. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur. Respir. J. 2002; 20: 841-845.
18. Lehtimaki L, Kankaanranta H, Saarelainen S, et al. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur. Respir. J. 2001; 18: 635-639.
19. Mahut B, Delacourt C, Zerah-Lancner F, et al. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 2004; 125: 1012-1018.
20. Berry M, Hargadon B, Morgan A, et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur. Respir. J. 2005; 25: 986-991.
21. Tunon-de-Lara JM, Laurent F, Giraud V, et al. Air trapping in mild and moderate asthma: effect of inhaled corticosteroids. J. Allergy Clin. Immunol. 2007; 119: 583-590.
22. Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 1997; 100: 44-51.
23. Minshall EM, Hogg JC, Hamid QA,. Cytokine mRNA expression in asthma is not restricted to the large airways. J. Allergy Clin. Immunol. 1998; 101: 386-390.
24. Saetta M, Di Stefano A, Rosina C, et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 1991; 143: 138-143.
25. Carroll N, Elliot J, Morton A, et al. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 1993; 147: 405-410.
26. Gelfand EW, Kraft M,. The importance and features of the distal airways in children and adults. J. Allergy Clin. Immunol. 2009; 124: S84-87.
27. Yasui H, Fujisawa T, Inui N, et al. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation. Respir. Med. 2012; 106: 508-514.
28. Mahut B, Delclaux C, Tillie-Leblond I, et al. Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. J. Allergy Clin. Immunol. 2004; 113: 252-256.
29. Brindicci C, Ito K, Barnes PJ, et al. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007; 131: 1353-1362.
30. van Veen IH, Sterk PJ, Schot R, et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur. Respir. J. 2006; 27: 951-956.
31. Kobayashi D, Tochino Y, Kanazawa H, et al. Comparison of alveolar nitric oxide concentrations using two different methods for assessing small airways obstruction in asthma. Respirology 2011; 16: 862-868.
32. Matsumoto H, Niimi A, Jinnai M, et al. Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma. Respiration 2011; 81: 311-317.
33. Gelb AF, George SC, Camacho F, et al. Increased nitric oxide concentrations in the small airway of older normal subjects. Chest 2011; 139: 368-375.